Prevalence of polypoidal choroidal vasculopathy in Indian population: Risk factors, clinical and imaging characteristics.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
15
11
2019
accepted:
02
04
2020
entrez:
29
4
2020
pubmed:
29
4
2020
medline:
25
7
2020
Statut:
epublish
Résumé
To assess prevalence, clinical presentation and multimodal imaging characteristics of polypoidal choroidal vasculopathy (PCV) in a hospital-based setting in South India. Electronic medical records (EMR) of new patients presenting with suspected clinical signs of wet age-related macular degeneration (AMD) in a tertiary hospital from January to December 2016 were retrospectively analyzed using keywords and filtered for patient who underwent multimodal imaging. Clinical presentations were categorized into predominantly hemorrhagic, exudative or mixed pattern. The imaging features were compared in these clinical groups. The multimodal images were graded by two masked graders and discrepancies between them were settled by a senior arbitrator. Of the 147 clinically suspicious cases of PCV out of 785 patients with clinical presentation of AMD as recorded in the EMR, 73 (49.7%) patients had a multimodal imaging diagnosis of PCV. There was no difference in the demography, distribution of polyps, ICGA and OCT characteristics in eyes presenting with hemorrhagic, exudative or mixed clinical features. Approximately half of South Asian patients presenting with clinical features of neovascular AMD harbor PCV irrespective of their clinical presentation and so we recommend that multimodal imaging is done in all cases of suspicious neovascular AMD in Indian population.
Identifiants
pubmed: 32343707
doi: 10.1371/journal.pone.0231901
pii: PONE-D-19-31766
pmc: PMC7188226
doi:
Banques de données
figshare
['10.6084/m9.figshare.11936607']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0231901Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Retina. 2001;21(2):121-5
pubmed: 11321137
Br J Ophthalmol. 2017 Oct;101(10):1377-1380
pubmed: 28270486
Ophthalmic Epidemiol. 2009 Sep-Oct;16(5):304-10
pubmed: 19874110
Ophthalmologica. 2014;231(2):59-74
pubmed: 24280967
Br J Ophthalmol. 2000 May;84(5):479-84
pubmed: 10781511
Am J Ophthalmol. 2002 May;133(5):639-48
pubmed: 11992861
Br J Ophthalmol. 2002 Aug;86(8):892-7
pubmed: 12140211
Retina. 2012 Feb;32 Suppl 1:416-34
pubmed: 22451953
Indian J Ophthalmol. 2018 Jul;66(7):896-908
pubmed: 29941728
Arch Ophthalmol. 2003 Oct;121(10):1392-6
pubmed: 14557174
J Clin Med. 2015 Apr 24;4(5):782-821
pubmed: 26239448
Am J Ophthalmol. 2007 Jul;144(1):15-22
pubmed: 17509509
Br J Ophthalmol. 2015 May;99(5):624-8
pubmed: 25758601
Eye (Lond). 2016 May;30(5):688-97
pubmed: 26915746
Surv Ophthalmol. 2010 Nov-Dec;55(6):501-15
pubmed: 20850857
Jpn J Ophthalmol. 2008 Jan-Feb;52(1):57-62
pubmed: 18369702
Clin Ophthalmol. 2017 Feb 09;11:317-322
pubmed: 28223776
Graefes Arch Clin Exp Ophthalmol. 2000 Sep;238(9):752-9
pubmed: 11045343
Eye (Lond). 2004 May;18(5):455-9
pubmed: 15131673
Arch Ophthalmol. 1999 Nov;117(11):1503-10
pubmed: 10565519
Retina. 2009 Feb;29(2):187-91
pubmed: 18827731
Ophthalmology. 2014 Nov;121(11):2290-1
pubmed: 25109927
Graefes Arch Clin Exp Ophthalmol. 2004 Aug;242(8):625-9
pubmed: 15257461
Graefes Arch Clin Exp Ophthalmol. 2007 Oct;245(10):1441-5
pubmed: 17406882